It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Infection by viruses, including herpes simplex virus-1 (HSV-1), and cellular stresses cause widespread disruption of transcription termination (DoTT) of RNA polymerase II (RNAPII) in host genes. However, the underlying mechanisms remain unclear. Here, we demonstrate that the HSV-1 immediate early protein ICP27 induces DoTT by directly binding to the essential mRNA 3’ processing factor CPSF. It thereby induces the assembly of a dead-end 3’ processing complex, blocking mRNA 3’ cleavage. Remarkably, ICP27 also acts as a sequence-dependent activator of mRNA 3’ processing for viral and a subset of host transcripts. Our results unravel a bimodal activity of ICP27 that plays a key role in HSV-1-induced host shutoff and identify CPSF as an important factor that mediates regulation of transcription termination. These findings have broad implications for understanding the regulation of transcription termination by other viruses, cellular stress and cancer.
Herpes simplex virus-1 (HSV-1) infection disrupts transcription termination (DoTT) of host genes, but underlying mechanisms are unclear. Here, Wang et al. show that the HSV-1 immediate early protein ICP27 induces DoTT through interaction with the mRNA 3’ processing factor CPSF and disruption of the processing complex.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 University of California, Irvine, Department of Microbiology and Molecular Genetics, School of Medicine, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
2 Julius-Maximilians-University Würzburg, Institute for Virology and Immunobiology, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658)
3 Ludwig-Maximilians-Universität München, Institute of Informatics, München, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X)
4 University of California, Irvine, Institute for Genomics and Bioinformatics, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243) ; University of California, Irvine, Department of Computer Science, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
5 University of Minnesota, Department of Biochemistry, Molecular Biology, and Biophysics, College of Biological Sciences, Saint Paul, USA (GRID:grid.17635.36) (ISNI:0000000419368657)
6 Julius-Maximilians-University Würzburg, Institute for Virology and Immunobiology, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658) ; Helmholtz Institute for RNA-based Infection Research, Würzburg, Germany (GRID:grid.498164.6)